| Reference |
|---|
Jover E, Matilla L, Garaikoetxea M, Fernández Celis A, Muntendam P, Jaisser F, et al. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines. 2021;9: pubmed publisher |
Yendo T, Sato M, Branco A, Pietrobon A, Teixeira F, Ramos Y, et al. Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. Vaccines (Basel). 2021;9: pubmed publisher |
Bobhate A, Viswanathan V, Aravindhan V. Anti-inflammatory cytokines IL-27, IL-10, IL-1Ra and TGF-β in subjects with increasing grades of glucose intolerence (DM-LTB-2). Cytokine. 2021;137:155333 pubmed publisher |
Jeon J, Lee Y, Yu H, Ha U. HSP70-Homolog DnaK of Pseudomonas aeruginosa Increases the Production of IL-27 through Expression of EBI3 via TLR4-Dependent NF-κB and TLR4-Independent Akt Signaling. Int J Mol Sci. 2020;21: pubmed publisher |
Genaro L, Coser L, Justo Júnior A, de Castro L, Barreto A, Rizzato A, et al. Association between IL-27 and Tr1 cells in severe form of paracoccidioidomycosis. Cytokine. 2020;127:154962 pubmed publisher |
Moideen K, Kumar N, Bethunaickan R, Banurekha V, Nair D, Babu S. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment. Cytokine. 2020;127:154929 pubmed publisher |
Zhang L, Zhang J, Su S, Luo S. Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance. Peerj. 2019;7:e5652 pubmed publisher |
Loughran S, Power P, Maguire P, McQuaid S, Buchanan P, Jonsdottir I, et al. Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-γ responses to pneumococcus in vitro in human monocytes. PLoS ONE. 2018;13:e0203521 pubmed publisher |
Busca A, Konarski Y, Gajanayaka N, O Hara S, Angel J, Kozlowski M, et al. cIAP1/2-TRAF2-SHP-1-Src-MyD88 Complex Regulates Lipopolysaccharide-Induced IL-27 Production through NF-κB Activation in Human Macrophages. J Immunol. 2018;200:1593-1606 pubmed publisher |
Nuñez S, Ziblat A, Secchiari F, Torres N, Sierra J, Raffo Iraolagoitia X, et al. Human M2 Macrophages Limit NK Cell Effector Functions through Secretion of TGF-? and Engagement of CD85j. J Immunol. 2018;200:1008-1015 pubmed publisher |
Golic N, Veljovic K, Popovic N, Djokic J, Strahinic I, Mrvaljević I, et al. In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens. BMC Microbiol. 2017;17:108 pubmed publisher |
Garg A, Trout R, Spector S. Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4. Sci Rep. 2017;7:44485 pubmed publisher |
Hojo Souza N, Pereira D, de Souza F, de Oliveira Mendes T, Cardoso M, Tada M, et al. On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease. Malar J. 2017;16:42 pubmed publisher |
Zhang Z, Zhou B, Zhang K, Song Y, Zhang L, Xi M. IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway. Mol Immunol. 2016;78:155-163 pubmed publisher |
Malecka A, Wang Q, Shah S, Sutavani R, Spendlove I, Ramage J, et al. Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation. J Leukoc Biol. 2016;100:381-9 pubmed publisher |
Teles R, Kelly Scumpia K, Sarno E, Rea T, Ochoa M, Cheng G, et al. IL-27 Suppresses Antimicrobial Activity in Human Leprosy. J Invest Dermatol. 2015;135:2410-2417 pubmed publisher |
Guha R, Das S, Ghosh J, Sundar S, Dujardin J, Roy S. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response. PLoS Negl Trop Dis. 2014;8:e2995 pubmed publisher |
Dietrich C, Candon S, Ruemmele F, Devergne O. A soluble form of IL-27R? is a natural IL-27 antagonist. J Immunol. 2014;192:5382-9 pubmed publisher |
Zhang X, Tao Y, Chopra M, Ahn M, Marcus K, Choudhary N, et al. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis. J Immunol. 2013;191:5867-74 pubmed publisher |
Lechner C, Komander K, Hegewald J, Huang X, Gantin R, Soboslay P, et al. Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly. Immun Ageing. 2013;10:29 pubmed publisher |
Fitzgerald D, Fonseca Kelly Z, Cullimore M, Safabakhsh P, Saris C, Zhang G, et al. Independent and interdependent immunoregulatory effects of IL-27, IFN-?, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis. J Immunol. 2013;190:3225-34 pubmed publisher |
Jiang S, Liu X, Luo L, Qu B, Huang X, Lin Y, et al. Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Mol Vis. 2011;17:1425-30 pubmed |
Sweeney C, Lonergan R, Basdeo S, Kinsella K, Dungan L, Higgins S, et al. IL-27 mediates the response to IFN-? therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun. 2011;25:1170-81 pubmed publisher |
Ramgolam V, Sha Y, Marcus K, Choudhary N, Troiani L, Chopra M, et al. B cells as a therapeutic target for IFN-? in relapsing-remitting multiple sclerosis. J Immunol. 2011;186:4518-26 pubmed publisher |
Guzzo C, Hopman W, Che Mat N, Wobeser W, Gee K. Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27. AIDS. 2010;24:1371-4 pubmed publisher |
Correale J, Farez M. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol. 2009;183:5999-6012 pubmed publisher |
